Mixed Phenotype Acute Leukemia Clinical Trials in Tulsa, Oklahoma

3 studies are recruiting for mixed phenotype acute leukemia in Tulsa, Oklahoma right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy and immunotherapy (chemo-immunotherapy) for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. Inotuzumab ozogamicin is a monoclonal antibody, which is a type of prote…

    Stage
    Phase 3
    Ages
    1 to 25
    Site
    Saint Francis Children's Hospital, Tulsa, Oklahoma
    Locations
    231 in total
    Run by
    Children's Oncology Group

    See if you can join NCT03959085 on ClinicalTrials.gov

  2. Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

    This is a clinical trial testing whether the addition of one of two chemotherapy agents, dasatinib or venetoclax, can improve outcomes for children and young adults with newly diagnosed T-cell acute lymphoblastic leukemia and lymphoma or mixed phenotype acute leukemia. Primary Objective * To evalua…

    Stage
    Phase 2
    Ages
    1 to 18
    Site
    Saint Francis Children's Hospital, Tulsa, Oklahoma
    Locations
    4 in total
    Run by
    St. Jude Children's Research Hospital

    See if you can join NCT06390319 on ClinicalTrials.gov

  3. Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

    The goal of this study is to provide sufficient therapy during the time a patients' B-cell Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LLy) risk category is being determined. The term "risk" refers to the chance of the ALL or LLy coming back after treatment. Primary Objectives * T…

    Stage
    Phase 4
    Ages
    1 to 18
    Site
    Saint Francis Children's Hospital, Tulsa, Oklahoma
    Locations
    5 in total
    Run by
    St. Jude Children's Research Hospital

    See if you can join NCT06289673 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.